Epithelial-Mesenchymal Transition gene database (dbEMT) Home
dbEMT
dbEMT 2.0
General information | Literature | Expression | lncRNA |Regulation | Mutation | Homolog | Interaction

Basic Information

Gene ID

3605

Name

IL17A

Gene Regulation:

Transcription Factors
Post Translational Modification From dbPTM
Methylation Profile From DiseaseMeth database

Transcription factors   [Top]

The investigation of TF-target regulations in human from AnimalTFDB 3.0 database and hTFtarget

Links to the hTFtarget for IL17A
Links to the AnimalTFDB for IL17A

Regulation From TransFac database

IL-17A(h) --> Jak1(h) (activation; phosphorylation)
IL-17A(h) --> Jak2(h) (activation; phosphorylation)
IL-17A(h) --> Jak3(h) (activation; phosphorylation)
IL-17A(h) --> Tyk2(h) (activation; phosphorylation)
IL-17A(h) --> STAT1(h) (activation; phosphorylation)
IL-17A(h) --> STAT2(h) (activation; phosphorylation)
IL-17A(h) --> STAT3(h) (activation; phosphorylation)
IL-17A(h) --> STAT4(h) (activation; phosphorylation)
IL-17A(h) --> IL-1beta(h) (activation)
IL-17A(h) --> TNF-alpha(h) (activation)
IL-17A(h) --> IL-6(h) (activation)
IL-17A(h) --> IL-10(h) (activation)
IL-17A(h) --> IL-1RA(h) (activation)
IL-17A(h) --> IL-12(h) (activation)
IL-17A(h) --> PGE2 (activation)
IL-17A(h) --> stromelysin1(h) (activation)
IL-17A(h) --> Ca (activation)
2 IL-17A(h) <==> (IL-17A(h))2 (binding)
IL-17F(h) + IL-17A(h) <==> IL-17F(h):IL-17A(h) (binding)
IL17A(h) --> IL-17A(h) (expression).
IL-17A(h) --> MMP1(h) (transactivation)
IL-17A(h) --> mmp1(h) (increase of abundance)
IL-17A(h) --> RelA-p65(h) (increase of abundance)
IL-17A(h) --> NF-kappaB1(h) (increase of abundance)
IL-17A(h) --> c-Fos(h) (increase of abundance)
IL-17A(h) --> FOSB(h) (increase of abundance)
IL-17A(h) --> c-Jun(h) (increase of abundance)
IL-17A(h) --> Fra-1(h) (increase of abundance)
IL-17A(h) --> JunD(h) (increase of abundance)
IL-17A(h) --> C/EBPbeta(h) (increase of abundance)
IL-17A(h) --> p38(h){p} (increase of abundance)
IL-17A(h) --> ATF-2(h){pT71} (increase of phosphorylation)
IL-17A(h) --> ERK1(h){p} (increase of phosphorylation)
IL-17A(h) --> ERK2(h){p} (increase of phosphorylation)
IL-17A(h) --> ELK(h){pS} (increase of phosphorylation)
IL-17A(h) --> mmp2(h) (increase of abundance)
IL-17A(h) --> stromelysin1(h) (increase of abundance)
IL-17A(h) --> gelatinase B(h) (increase of abundance)
IL-17A(h) --> MMP-13(h) (increase of abundance)
IL-17A(h) --> TIMP-1(h) (increase of abundance)
IL-17A(h) + IL-17RC(h) <==> IL-17A(h):IL-17RC(h) (binding)
IL-17A(h) + IL-17RA(h) <==> IL-17A(h):IL-17RA(h) (binding)
IL-17A(h) --> IL-8(h) (increase of secretion)
IL-17A(h) --> IL-6(h) (increase of secretion)
IL-17A(h) --> GROalpha(h) (increase of secretion)
IL-17A(h) + IL-17RC(m) <==> IL-17A(h):IL-17RC(m) (binding)
IL-17A(h) --> G-CSF(h) (increase of secretion)
IL-17A(h) --> MCP-1(h) (increase of secretion)
IL-17A(h) --> IkappaB-alpha(m){p} (increase of phosphorylation)
2 IL-17A(h) <==> (IL-17A(h))2 (binding; oligomerization)
IL-17A(h) --> DEFB4(h) (transactivation)
IL-17A(h) + NDP-Gly --> IL-17A(h){gly} + NMP (glycosylation)
IL-17A(h) --> prostaglandin E synthase 2(h) (increase of secretion)
IL-17A(h) --> IL19(h) (transactivation)
IL-17A(h) --> CXCL1(h) (transactivation)
IL-17A(h) --> CXCL2(h) (transactivation)
IL-17A(h) --> GRO3(h) (transactivation)
IL-17A(h) --> CXCL5(h) (transactivation)
IL-17A(h) --> CXCL6(h) (transactivation)
IL-17A(h) --> PIP3 (increase of secretion)
IL-17A(h) --> AKT-1(h){pT308}{pS473} (increase of phosphorylation)
IL-17A(h) --> GROalpha(m) (increase of secretion)
IL-17A(h) + IL-17F(h) <==> IL-17A(h):IL-17F(h) (binding)
IL-17A(h) --> GSK3beta(h){pS9} (increase of phosphorylation)
IL-17A(h) --> IL1B(h) (transactivation)
IL-17A(h) --> NOS2(h) (transactivation)
IL-17A(h) --> Jak2(h){pY1007}{pY1008} (increase of phosphorylation)
IL-17A(h) --> Jak1(h){pY} (increase of phosphorylation)
IL-17A(h) --> PTGS2(h) (transactivation)
IL-17A(h) --> IL6(h) (transactivation)
IL-17A(h) --> iNOS(h) (increase of abundance)
IL-17A(h) --> STAT3(h){pY705} (increase of phosphorylation)
IL-17A(h) --> CRP(h) (transactivation)
IL-17A(h) --> IL8(h) (transactivation)
IL-17A(h) --> Muc5AC(h) (increase of secretion)
IL-17A(h) --> Cxcl1(m) (transactivation)
IL-17A(h) --> ERK1(h){pT202}{pY204} (increase of phosphorylation)
IL-17A(h) --> ERK2(h){pT185}{pY187} (increase of phosphorylation)
IL-17A(h) --> COX2(h) (increase of abundance)
IL-17A(h) --> p38(b){p} (increase of phosphorylation)
IL-17A(h) --> ERK1(b){p} (increase of phosphorylation)
IL-17A(h) --> ERK2(b){p} (increase of phosphorylation)
IL-17A(h) --> JNK1(h){p} (increase of phosphorylation)
IL-17A(h) --/ IkappaB-alpha(b) (decrease of abundance)
IL-17A(h) --> S100A7(h) (transactivation)
IL-17A(h) --> S100A8(h) (transactivation)
IL-17A(h) --> S100A9(h) (transactivation)
IL-17A(h) --/ IkappaB-alpha(h) (decrease of abundance)
IL-17A(h) --> NFKBIZ(h) (transactivation)
IL-17A(h) --> CRP(h) (increase of secretion)
IL-17A(h) --> c-Rel(h) (increase of abundance)
IL-17A(h) --> C/EBPalpha(h) (increase of abundance)
IL-17A(h) --> C/EBPbeta(h){pT235} (increase of phosphorylation)
IL-17A(h) --> p38alpha(h){pT180}{pY182} (increase of phosphorylation)
IL-17A(h) --> Nfkbiz(m) (transactivation)
IL-17A(h) --> Fas(m) (transactivation)
IL-17A(h) --> Ccl2(m) (transactivation)
IL-17A(h) --> Beta-defensin2(h) (increase of secretion)
IL-17A(h) --> Defb3(m) (transactivation)
IL-17A(h) --> CCL20(h) (transactivation)
IL-17A(h) --> Ccl20(m) (transactivation)
IL-17A(h) --> MIP-3alpha(h) (increase of secretion)
IL-17A(h) --> p38(h){pT}{pY} (increase of phosphorylation)
IL-17A(h) --> eotaxin-1(h) (increase of secretion)
IL-17A(h) --> CCL11(h) (transactivation)
IL-17A(h) --> JNK(h){pT}{pY} (increase of phosphorylation)
IL17A(h) --> IL-17A(h) (expression).

Post Translational Modification   [Top]

Location (AA)

PTM type

Literature

Database

68N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0

Methylation Profile   [Top]

There is no record for IL17A



')